Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apevinat BC is a combination medication that contains cyproheptadine hydrochloride as its primary active ingredient, along with B complex vitamins and vitamin C[1][4]. This formulation is specifically designed for patients with anorexia (lack of appetite) or those with diets lacking necessary vitamins[1]. The medication presents cyproheptadine hydrochloride, which functions as an antihistamine and anti-serotonin agent with appetite stimulant properties[1]. This active ingredient is combined with B complex vitamins and vitamin C in balanced amounts to create a synergistic effect[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Apevinat BC.